These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31742997)

  • 1. Adoption of a Turn Conformation Drives the Binding Affinity of p53 C-Terminal Domain Peptides to 14-3-3σ.
    Kuusk A; Neves JF; Bravo-Rodriguez K; Gunnarsson A; Ruiz-Blanco YB; Ehrmann M; Chen H; Landrieu I; Sanchez-Garcia E; Boyd H; Ottmann C; Doveston RG
    ACS Chem Biol; 2020 Jan; 15(1):262-271. PubMed ID: 31742997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
    Fadda E; Nixon MG
    Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of Amphipathic Cell Penetrating Peptide p28 to Wild Type and Mutated p53 as studied by Raman, Atomic Force and Surface Plasmon Resonance spectroscopies.
    Signorelli S; Santini S; Yamada T; Bizzarri AR; Beattie CW; Cannistraro S
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):910-921. PubMed ID: 28126403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
    Ithuralde RE; Turjanski AG
    PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2.
    Yadahalli S; Neira JL; Johnson CM; Tan YS; Rowling PJE; Chattopadhyay A; Verma CS; Itzhaki LS
    Sci Rep; 2019 Jan; 9(1):693. PubMed ID: 30679555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated full-length Tau interacts with 14-3-3 proteins via two short phosphorylated sequences, each occupying a binding groove of 14-3-3 dimer.
    Neves JF; Petrvalská O; Bosica F; Cantrelle FX; Merzougui H; O'Mahony G; Hanoulle X; Obšil T; Landrieu I
    FEBS J; 2021 Mar; 288(6):1918-1934. PubMed ID: 32979285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution conformation of an essential region of the p53 transactivation domain.
    Botuyan MV; Momand J; Chen Y
    Fold Des; 1997; 2(6):331-42. PubMed ID: 9427007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis for the Interaction between p53 Transactivation Domain and the Mediator Subunit MED25.
    Lee MS; Lim K; Lee MK; Chi SW
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.
    Yakovleva T; Pramanik A; Kawasaki T; Tan-No K; Gileva I; Lindegren H; Langel U; Ekstrom TJ; Rigler R; Terenius L; Bakalkin G
    J Biol Chem; 2001 May; 276(19):15650-8. PubMed ID: 11279079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer.
    Schumacher B; Mondry J; Thiel P; Weyand M; Ottmann C
    FEBS Lett; 2010 Apr; 584(8):1443-8. PubMed ID: 20206173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R248Q mutation--Beyond p53-DNA binding.
    Ng JW; Lama D; Lukman S; Lane DP; Verma CS; Sim AY
    Proteins; 2015 Dec; 83(12):2240-50. PubMed ID: 26442703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the relationship between the p53 C-terminal domain and its binding partners using molecular dynamics.
    Allen WJ; Capelluto DG; Finkielstein CV; Bevan DR
    J Phys Chem B; 2010 Oct; 114(41):13201-13. PubMed ID: 20873738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition.
    Shin JS; Ha JH; Lee DH; Ryu KS; Bae KH; Park BC; Park SG; Yi GS; Chi SW
    Cell Cycle; 2015; 14(4):533-43. PubMed ID: 25591003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design using sequence information only produces a peptide that binds to the intrinsically disordered region of p53.
    Kamagata K; Mano E; Itoh Y; Wakamoto T; Kitahara R; Kanbayashi S; Takahashi H; Murata A; Kameda T
    Sci Rep; 2019 Jun; 9(1):8584. PubMed ID: 31253862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the conformational landscape of MDM2-binding p53 peptides using Molecular Dynamics simulations.
    Yadahalli S; Li J; Lane DP; Gosavi S; Verma CS
    Sci Rep; 2017 Nov; 7(1):15600. PubMed ID: 29142290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
    Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
    Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding and structural polymorphism of p53 C-terminal domain: One peptide with many conformations.
    Kumar A; Kumar P; Kumari S; Uversky VN; Giri R
    Arch Biochem Biophys; 2020 May; 684():108342. PubMed ID: 32184088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the C-terminal sites of human p53 reduces non-sequence-specific DNA binding as modeled with synthetic peptides.
    Hoffmann R; Craik DJ; Pierens G; Bolger RE; Otvos L
    Biochemistry; 1998 Sep; 37(39):13755-64. PubMed ID: 9753464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain.
    Wright JD; Noskov SY; Lim C
    Nucleic Acids Res; 2002 Apr; 30(7):1563-74. PubMed ID: 11917017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.